VPDs with very short coupling intervals developing during an acute stage of myocardial infarction would predict the development of early cycled reentry, potentially culminating in VF, and requires ...

AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced ...

AtaCor Medical launched its clinical study evaluating its extravascular implantable cardioverter defibrillator (EV-ICD) lead ...

The FDA approved Kerendia in July 2021 for adults with chronic kidney disease associated with Type 2 diabetes to reduce the ...

Brugada syndrome (BrS) is a complex cardiac condition associated with sudden cardiac death, characterized by distinct electrocardiogram (ECG) patterns. This ...

Milestone Pharmaceuticals Inc.’s MIST share price has dipped by 60.44%, which has investors questioning if this is right time to buy.

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a ...

It has been found that electric shock may derange heart action causing ventricular fibrillation without damage to heart tissue, but resulting in death within a few minutes. This heart effect ...

Milestone (WA: MMD )’s President and CEO, Joe Oliveto, expressed the company’s disappointment with the CRL but reaffirmed their commitment to CARDAMYST as a potential novel treatment for PSVT. The ...

Atrial fibrillation (AF) and chronic heart failure ... options for prevention of AF in patients with ventricular dysfunction. In conclusion, AF is associated with increased mortality in CHF ...

Discover how AI in life sciences enhances disease diagnosis, enabling faster, more accurate detection and improving patient ...